Literature DB >> 27226877

Detection of Human Metapneumovirus and Respiratory Syncytial Virus by Real-Time Polymerase Chain Reaction Among Hospitalized Young Children in Iran.

Masoud Parsania1, Behzad Poopak2, Mohammad Hassan Pouriayevali3, Sama Haghighi4, Aref Amirkhani5, Alireza Nateghian6.   

Abstract

BACKGROUND: Acute respiratory infection plays an important role in hospitalization of children in developing countries; detection of viral causes in such infections is very important. The respiratory syncytial virus (RSV) is the most common etiological agent of viral lower respiratory tract infection in children, and human metapneumovirus (hMPV) is associated with both upper and lower respiratory tract infections among infants and children.
OBJECTIVES: This study evaluated the frequency and seasonal prevalence of hMPV and RSV in hospitalized children under the age of five, who were admitted to Aliasghar children's hospital of Iran University of Medical Sciences from March 2010 until March 2013. PATIENTS AND METHODS: Nasopharyngeal or throat swabs from 158 hospitalized children with fever and respiratory distress were evaluated for RSV and hMPV RNA by the real-time polymerase chain reaction (PCR) method.
RESULTS: Among the 158 children evaluated in this study, 49 individuals (31.1%) had RSV infection while nine individuals (5.7%) had hMPV infection. Five (55.5%) of the hMPV-infected children were male while four (44.5%) were female and 27 (55.2%) of the RSV-infected patients were females and 22 (44.8%) were males. The RSV infections were detected in mainly < one year old children and hMPV infections were detected mainly in > one year old children. Both RSV and hMPV infections had occurred mainly during winter and spring seasons.
CONCLUSIONS: Respiratory syncytial virus was the major cause of acute respiratory infection in children under one-year of age while human metapneumovirus had a low prevalence in this group. The seasonal occurrence of both viruses was the same.

Entities:  

Keywords:  Children, PCR; Human Metapneumovirus; Respiratory Syncytial Virus

Year:  2016        PMID: 27226877      PMCID: PMC4877467          DOI: 10.5812/jjm.32974

Source DB:  PubMed          Journal:  Jundishapur J Microbiol        ISSN: 2008-3645            Impact factor:   0.747


1. Background

Acute Respiratory Infection (ARI) is the major cause of morbidity and mortality worldwide, especially in young children. Respiratory viruses such as Respiratory syncytial virus (RSV), influenza virus type A and B, Parainfluenza virus 1-3 and adenovirus are the most common pathogens affecting the respiratory tract of young children (1). Human Metapneumovirus (hMPV) is associated with both upper and lower respiratory tract infections among infants and children worldwide (2). It was first identified as a novel respiratory virus in 2001 among children with ARI in the Netherlands. The hMPV belongs to the Paramyxoviridae family, Pneumovirinae subfamily, and the genus Metapneumovirus (3, 4). The RSV is the most common etiological agent of viral lower respiratory tract infection and is considered as the most important cause of viral bronchiolitis in children. Respiratory syncytial virus belongs to the Paramyxoviridae family, Pneumovirinae subfamily, and is placed under the genus Pneumovirus (5, 6). The clinical presentation of hMPV infection ranges from a mild upper respiratory tract infection to severe lower respiratory tract disease accompanied by bronchiolitis and pneumonia (6). While RSV, Influenza virus and Parainfluenza virus are considered to be the most common respiratory viruses, the role of other less known viruses such as hMPV in ARI children remains largely unknown (7). Despite studies showing the prevalence of hMPV infection, the actual role of hMPV in children with severe ARI in Iran is poorly understood. Molecular techniques such as the polymerase chain reaction (PCR) are sensitive methods to define respiratory viruses that may be present in clinical specimens, especially in children suffering from respiratory infections (8).

2. Objectives

This study had two objectives. First, to determine the hMPV and RSV frequency and their co-infection in hospitalized ARI children, aged less than five years old, at one of the children’s referral hospitals in Iran. Second, to describe the seasonal prevalence of hMPV and RSV among this group from March 2010 till March 2013.

3. Patients and Methods

3.1. Patients and Samples

This descriptive study was based on the processing of nasopharyngeal or throat swabs from 158 children, aged under five years old, who were admitted to Aliasghar children hospital of Iran University of Medical Sciences with acute respiratory infections from March 2010 till March 2013; this was done for the determination of the frequency of hMPV and RSV infections and co-infections. The ARI children aged less than five years, having tachypnea with or without respiratory distress and cough, were included in this study. Children with ARI, aged above five years old, were excluded. The specimens were placed into a vial containing 1 mL of transport media and were sent to the Payvand clinical and specialty laboratory, where they were tested by real-time polymerase chain reaction for hMPV and RSV. The samples were divided into aliquots and stored at -80°C until use.

3.2. Nucleic Acid Extraction and cDNA Synthesis

Nucleic acids from specimens were extracted using the QIAamp viral RNA extraction mini kit (Qiagen GmbH, Hiden, Germany), according to the manufacturer’s recommended protocol. Reverse transcription was performed with the use of random hexamers and SuperScript first-strand (invitrogen), according to the manufacture’s instructions.

3.3. Real-Time Polymerase Chain Reaction

Real-time PCR was done using the Rotor-Gene 6000 from Corbet Research (Australia). The properties of the oligonucleotide primers and probes of hMPV and RSV are shown in Table 1 (9). The limit of detection for the hMPV and RSV real-time PCR are 100 copies per reaction. There are no cross-reaction between both viruses and other respiratory viruses such as influenza virus A and influenza virus B, parainfluenza virus 1 to 4, and adenovirus, implying a high specificity. Beta-2-microglobulin (B2-MG) DNA was used as the internal control to monitor nucleic acid extraction. The sequence of the primer and the probe of B2-MG are shown in Table 1 (10).
Table 1.

Primers and Probes Used for the Real-Time Polymerase Chain Reaction

Primer Or Probe NamePrimer Or Probe Sequence (5'-3')Target Gene
hMPV-F CAAGTGTGACATTGCTGAYCTRAAF
hMPV-R ACTGCCGCACAACATTTAGRAAF
hMPV-P FAM-TGGCYGTYAGCTTCAGTCAATTCAACAGAF
RSV-F AACAGATGTAAGCAGCTCCGTTATCF
RSV-R CGATTTTTATTGGATGCTGTACATTTF
RSV-P FAM-TGCCATAGCATGACACAATGGCTCCTF
B2-MG-F TGAGTATGCCTGCCGTGTGAB2-MG
B2-MG-R TGATGCTGCTTACATGTCTCGATB2-MG
B2-MG-P FAM-CCATGTGACTTTGTCACAGCCCAAGATAGTTB2-MG

Abbreviations: B2-MG, beta-2-microglobulin; F, fusion.

Abbreviations: B2-MG, beta-2-microglobulin; F, fusion. The PCR conditions were as follows: reverse transcription at 50°C for 30 minutes, initial PCR denaturation at 95°C for 10 minutes, followed by 45 cycles of denaturation at 95°C for 15 seconds, annealing at 58°C for 60 seconds. The positive controls comprised of cDNA of the viruses, provided by professor Dr. Eric C. J. Claas (Leiden university medical center, the Netherlands.). The cycle threshold values of ≤ 39.9 were regarded as positive and cycle threshold values of ≥ 40 were regarded as negative. The results were discarded for any specimen with a negative internal control.

3.4. Statistical Analysis

Statistical analysis for comparison of relative values was performed by the z-test, using the STATA software version 8. P < 0.05 were considered statistically significant.

4. Results

4.1. Study Population

From March 2010 to March 2013, 158 specimens were obtained from hospitalized children under five years old for evaluation of RSV and hMPV infections. The majority of respiratory specimens (more than 65%) were from children less than one year old.

4.2. Respiratory Syncytial Virus and Human Metapneumovirus Prevalence

Overall, 31.1% (49/158) of samples were positive for RSV, and 5.7% (9/158) of the specimens were positive for hMPV. Among the 158 patient specimens, 63.2% (100/158) were negative for RSV and hMPV (Table 2). Respiratory syncytial virus and hMPV co-infection was not observed among them.
Table 2.

Absolute and Relative Frequency of Respiratory Syncytial Virus and Human Metapneumovirus Among 158 Children With Acute Respiratory Infections in Accordance with Different Age Groups[a]

Age GroupsSpecimens TestedSpecimens PositiveRSVhMPV
< 6 months 78 (49.4)30 (19)29 (18.4)1 (0.6)
6 - 12 months 26 (16.4)8 (5.1)6 (3.8)2 (1.3)
1 - 2 years 20 (12.7)10 (6.3)8 (5.1)2 (1.3)
2 - 5 years 34 (21.5)10 (6.3)6 (3.8)4 (2.5)
Total 158 (100)58 (36.7)49 (31.1)9 (5.7)

aValues are expressed as No. (%)

aValues are expressed as No. (%)

4.3. Age and Gender Distribution of Respiratory Syncytial Virus and Human Metapneumovirus infections

Twenty-seven (55.2%) of the RSV-infected patients were females and 22 (44.8%) were males. Five (55.5%) of the hMPV-infected children were male while four (44.5%) were female. There were no significant differences between males and females. All patients with positive results for RSV and hMPV were divided into four age groups: < 6 months, 6 - 12 months, 1 - 2 years and 2 - 5 years. In the < 6 months group, the proportion of RSV cases was significantly greater (P < 0.05) than the proportion of hMPV cases, while in the children with 6 - 12 months, 1 - 2 years and 2 - 5 years, the proportions of RSV and hMPV were nearly the same (Table 2).

4.4. Seasonal Prevalence of Respiratory Syncytial Virus and Human Metapneumovirus Infections

The seasonal distribution of detected viruses over the three-year study period is shown in Figure 1, during which two peaks of RSV infections occurred annually, first during December 2010 to February 2011 (31.4%) and the second during December 2011 to February 2012 (53%). The hMPV infections were mainly detected from December 2010 to February 2011 and December 2012 to February 2013, when 11.4% and 15.4% of infections occurred, respectively.
Figure 1.

Seasonal Prevalence Rate of Human and Respiratory Syncytial Virus Infections Plotted From March 2010 to December 2013

5. Discussion

The study shows that 31.1% and 5.7% of RSV and hMPV infections, respectively, occurred among Iranian children < 5 years of age, hospitalized with acute respiratory tract infections. The prevalence of hMPV infection in Iranian children with ARI varied from 0.49% to 54.4%, which was not previously reported in Iran (11, 12). Herein, the proportion of acute respiratory infection of hMPV-positive cases among children under the age of 5 in our study (5.7%) was similar to studies from the Middle-East regions such as Amman (6%) and other regions such as Brazil (5.6%) (7, 13). There are also other reports on the frequency of RSV in hospitalized children in Iran. Pourakbari et al. (14) studied hospitalized children under five years old with acute respiratory tract infection and found a prevalence of 17.2% for RSV, and Malekshahi et al. (11) assessed RSV among children less than six years old with ARI and reported that it was the cause of 16.8% cases (11, 14). In another study Nikfar et al. (15) observed that among 100 children with acute respiratory infection, 9% were infected with RSV. The above-mentioned results were lower than what was found in this study (31.1%), which is more similar to the findings of Moattari et al. (16) on hospitalized children with acute respiratory infection in south of Iran. They found that among 280 children under five years old, 84 (30.0%) were infected with RSV. There are several studies showing co-infection with RSV and hMPV (3, 5). Moattari et al. (16) observed that 10 (3.5%) of the studied patients were infected with both viruses, yet in the current study there was no co-infection with RSV and hMPV, which was similar to the findings of Mullins et al.(17). The difference between the prevalence rate of hMPV and RSV infections and co-infection with both viruses in several studies may be described by different groups of patients, methods used for detection of viruses, yearly variation in incidence and other variables, such as age, population density, socioeconomic factor and climate changes. It was also found that hMPV-infected children were older than RSV-infected cases. The RSV was found predominantly in children < 1 year old, while hMPV infection occurred mainly in children aged 1 - 5 years. Such finding is similar to other studies on hMPV epidemiology (17-20). The reason of such difference may be explained by longer lasting maternal immunity to hMPV compared with RSV. The hMPV seasonal distribution was determined by the peaks within the winter and the spring. This finding was observed in other hMPV studies as well (8, 21). In addition, RSV infection occurred largely during the winter months, similar to those previously observed elsewhere(5, 7, 22, 23). In accordance with several studies, the seasonal occurrence of hMPV infection mainly overlaps with RSV infections (8, 24). Hence it seems that hMPV is less important than RSV as a cause of ARI, especially in children under one year old and the seasonal occurrence of both viruses is the same. Large-scale follow-up epidemiological studies are needed to fully explore all respiratory viruses causing ARI in Iranian young children and assess seasonally patterns.
  22 in total

1.  Human respiratory syncytial virus and metapneumovirus in patients with acute respiratory infection in Colombia, 2000 - 2011.

Authors:  Juliana Barbosa Ramirez; Paola Pulido Dominguez; Gloria Rey Benito; Jairo Mendez Rico; Jaime Castellanos; Andrés Páez Martinez
Journal:  Rev Panam Salud Publica       Date:  2014-08

2.  Detection of human bocavirus and human metapneumovirus by real-time PCR from patients with respiratory symptoms in Southern Brazil.

Authors:  Diogo André Pilger; Vlademir Vicente Cantarelli; Sérgio Luis Amantea; Sandra Leistner-Segal
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-02       Impact factor: 2.743

3.  Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.

Authors:  F Watzinger; M Suda; S Preuner; R Baumgartinger; K Ebner; L Baskova; H G M Niesters; A Lawitschka; T Lion
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Respiratory viruses in children younger than five years old with acute respiratory disease from 2001 to 2004 in Uberlândia, MG, Brazil.

Authors:  L F Costa; J Yokosawa; O C Mantese; T F M Oliveira; H L Silveira; L L Nepomuceno; L S Moreira; G Dyonisio; L M G Rossi; R C Oliveira; L Z G Ribeiro; D A O Queiróz
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-05       Impact factor: 2.743

5.  Human metapneumovirus in hospitalized children in Amman, Jordan.

Authors:  Syed Asad Ali; John V Williams; Qingxia Chen; Sameer Faouri; Sameer Faori; Assem Shehabi; Eshan Al Jundi; Najwa Khuri-Bulos; Natasha Halasa
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

6.  The highest prevalence of human metapneumovirus in Ahwaz children accompanied by acute respiratory infections.

Authors:  M Arabpour; A R Samarbafzadeh; M Makvandi; A Shamsizadeh; E Percivalle; Janet Englud; Seid Mannut Latifi
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

7.  Human metapneumovirus: a new pathogen in children and adults.

Authors:  J M Prins; K C Wolthers
Journal:  Neth J Med       Date:  2004-06       Impact factor: 1.422

8.  Burden of human metapneumovirus infection in young children.

Authors:  Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Caroline B Hall; Peter G Szilagyi; Mary A Staat; Marika Iwane; Mila M Prill; John V Williams
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

9.  Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses.

Authors:  Samantha Bosis; Susanna Esposito; Hubert G M Niesters; Piero Crovari; Albert D M E Osterhaus; Nicola Principi
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

10.  Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.

Authors:  John P McCracken; Wences Arvelo; José Ortíz; Lissette Reyes; Jennifer Gray; Alejandra Estevez; Oscar Castañeda; Gayle Langley; Kim A Lindblade
Journal:  Influenza Other Respir Viruses       Date:  2014-04-25       Impact factor: 4.380

View more
  4 in total

1.  Human bocavirus and human metapneumovirus in hospitalized children with lower respiratory tract illness in Changsha, China.

Authors:  Jie-Ying Zhou; Ying Peng; Xiao-You Peng; Han-Chun Gao; Ya-Ping Sun; Le-Yun Xie; Li-Li Zhong; Zhao-Jun Duan; Zhi-Ping Xie; You-de Cao
Journal:  Influenza Other Respir Viruses       Date:  2018-01-11       Impact factor: 4.380

2.  Evaluation of Human Respiratory Syncytial Virus and Human Parainfluenza Virus Type 3 among Hospitalized Children in Northwest of Iran.

Authors:  Zahra Ramezannia; Javid Sadeghi; Shahram Abdoli Oskouie; Mohammad Ahangarzadeh Rezaee; Hossein Bannazadeh Baghi; Arezou Azadi; Mahin Ahangar Oskouee
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-09-22       Impact factor: 2.471

3.  Molecular detection and genetic characterization of human metapneumovirus strains circulating in Islamabad, Pakistan.

Authors:  Yasir Arshad; Muhammad Suleman Rana; Aamer Ikram; Muhammad Salman; Uzma Bashir Aamir; Syed Sohail Zahoor Zaidi; Muhammad Masroor Alam; Salmaan Sharif; Shahzad Shaukat; Adnan Khurshid; Rabia Hakim; Ghulam Mujtaba; Massab Umair; Sadia Sattar; Nazish Bostan
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

4.  Hospital utilization rates for influenza and RSV: a novel approach and critical assessment.

Authors:  Emily K Johnson; Dillon Sylte; Sandra S Chaves; You Li; Cedric Mahe; Harish Nair; John Paget; Tayma van Pomeren; Ting Shi; Cecile Viboud; Spencer L James
Journal:  Popul Health Metr       Date:  2021-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.